Colchicine Dosing for Gout
Treatment of Acute Gout Flares
For acute gout attacks, administer colchicine 1.2 mg (two tablets) at the first sign of flare, followed by 0.6 mg (one tablet) one hour later, for a total maximum dose of 1.8 mg over one hour. 1
This low-dose regimen is as effective as the older high-dose protocols but with significantly fewer gastrointestinal adverse effects 2. Higher doses have not been found to be more effective 1. The key is early administration—ideally within 12 hours of symptom onset 3, 4.
Critical Timing Point
- If already on prophylactic colchicine when a flare occurs: Give the acute treatment dose (1.2 mg followed by 0.6 mg one hour later), then wait 12 hours before resuming the prophylactic dose 1
Prophylaxis When Starting Urate-Lowering Therapy
Initiate colchicine 0.6 mg once or twice daily (maximum 1.2 mg/day) when starting urate-lowering therapy, and continue for 3-6 months. 5, 1
The 2020 ACR guideline strongly recommends anti-inflammatory prophylaxis when initiating urate-lowering therapy, with moderate certainty evidence supporting continuation for at least 3-6 months 5. This recommendation is based on 8 RCTs and 2 observational studies showing that shorter durations are associated with flares upon cessation.
Dosing Nuances for Prophylaxis
- Standard dose: 0.6 mg once or twice daily
- Lower dose option: Recent evidence suggests 0.6 mg once daily (low-dose) may be adequate with fewer adverse events compared to 1.2 mg daily, though 1.2 mg daily may reduce pain intensity during breakthrough flares 6, 7
- The FDA label supports prophylactic therapy for "at least the first six months" of urate-lowering therapy 1
Important Caveat
A 2023 non-inferiority trial found that placebo was not non-inferior to colchicine 0.5 mg daily when using "start-low go-slow" allopurinol escalation, with significantly more flares in the placebo group (0.61 vs 0.35 flares/month) 8. This reinforces that prophylaxis remains necessary even with gradual allopurinol titration.
Dose Adjustments for Drug Interactions and Renal Impairment
Strong CYP3A4 or P-glycoprotein Inhibitors
If taking strong CYP3A4 inhibitors (clarithromycin, ketoconazole, ritonavir, etc.), colchicine is contraindicated for acute gout treatment. 1
For prophylaxis with these drugs:
- Reduce from 0.6 mg twice daily to 0.3 mg once daily
- Reduce from 0.6 mg once daily to 0.3 mg every other day
- Fatal colchicine toxicity has been reported with clarithromycin 1
Renal Impairment
- Mild (eGFR 60-89): No adjustment needed 9
- Moderate (eGFR 30-59): Consider 0.48-0.5 mg daily for prophylaxis 9
- Severe (eGFR 15-29): Reduce to 0.3 mg daily for prophylaxis 9
- Colchicine is contraindicated in patients with renal impairment who are also taking strong CYP3A4 or P-gp inhibitors 2
Key Safety Considerations
First Sign of Toxicity
Diarrhea is the first symptom of colchicine poisoning—reduce dose immediately if this occurs. 3
Monitoring
- Watch for gastrointestinal symptoms (diarrhea, nausea, vomiting, cramping)
- Therapeutic drug monitoring has limited clinical value, as colchicine concentrations do not consistently correlate with efficacy or adverse events 10
- Concomitant statin use increases colchicine concentrations but does not consistently result in muscle adverse events 10
Common Pitfall
Many clinicians still use outdated high-dose regimens or incorrect dosing intervals. The evidence clearly shows that 1.8 mg total over one hour is optimal for acute flares—not the older regimen of repeated hourly doses totaling 4.8 mg 2, 1.